Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone effectively treats female acne with few side effects.

Chronic stress can reduce skin pigmentation.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Block and replace therapy improved symptoms in recurrent cyclic Cushing’s disease.

New treatments for hair loss focus on targeting specific causes to improve effectiveness and safety.

Targeting neurosteroids may help prevent drug relapse.

Low-dose oral minoxidil is safe for alopecia patients, even those prone to edema.

Using minoxidil on dogs can cause serious cardiovascular damage, including arterial injury and hemorrhagic lesions.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Some dibenzo compounds might help treat cancer with fewer side effects.

Minoxidil is a primary treatment for hair loss but its exact working method is unknown.

New compounds may help treat prostate issues without affecting androgen receptors.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

A test for nail fungus was most accurate with PAS stain, low-dose spironolactone helped two-thirds of acne patients, metformin reduced symptoms of HIV-related fat distribution changes with some side effects, and skin examination with dermoscopy was better at detecting abnormal moles, while temporary tattoos can cause skin reactions.

Both azathioprine and betamethasone treatments help with hair regrowth in alopecia areata, but azathioprine may have fewer side effects.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Minoxidil works well as a high permeability reference drug for biopharmaceutics classification.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

Increased 11β-HSD1 activity in skin may contribute to aging and could be targeted to reduce aging effects.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

5-alpha reductase inhibitors slightly increase depression risk, but the risk varies based on the control group used.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

New minoxidil compounds with better water solubility were made, but their full effects and safety need more research.